TGFB1 and uterine corpus leiomyoma: Vitamin D3 produces therapeutic effects for uterine leiomyomas through its dual action of controlling TGF-β-responsive genes and its blocking effect on Wnt/β-catenin and mammalian target of rapamycin (mTOR) signaling pathways.